Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity

doi:10.1084/jem.172.1.61

This Article

Full Text (PDF, 1023K)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Scala, G.

Articles by Venuta, S.

Search for Related Content

PubMed

PubMed Citation

Articles by Scala, G.

Articles by Venuta, S.

Pubmed/NCBI databases

Substance via MeSH

Social Bookmarking

What's this?

ARTICLES

Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigenicity

G Scala, I Quinto, MR Ruocco, A Arcucci, M Mallardo, P Caretto, G Forni and S Venuta
Dipartimento di Biochimica e Biotecnologie Mediche, II Facolta di Medicina, Napoli, Italy.

The biological role of interleukin 6 (IL-6) molecules in human B cell tumorigenesis was studied by using an episomal expression vector, pHEBoSV-IL6, to introduce stably the human IL-6 gene into human Epstein Barr virus (EBV)-transformed B lymphoblasts. The gene was present in the IL-6-transfected cells in a high copy number and was efficiently expressed, resulting in the secretion of consistent levels of IL-6 molecules. The constitutive expression of the IL-6 gene led to an altered pattern of growth and to a malignant phenotype, as shown by clonogenicity in to an altered pattern of growth and to a malignant phenotype, as shown by clonogenicity in soft agar cultures and tumorigenicity in nude mice. These data suggest that the combined action of EBV, which exerts an immortalizing function, and of the growth-promoting activity of IL-6 molecules, can give rise to fully transformed B cell tumors in immunodeficient subjects.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Gatto, G., Rossi, A., Rossi, D., Kroening, S., Bonatti, S., Mallardo, M. (2008). Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-{kappa}B pathway. Nucleic Acids Res 36: 6608-6619 [Abstract] [Full Text]
Wu, Y., Maruo, S., Yajima, M., Kanda, T., Takada, K. (2007). Epstein-Barr Virus (EBV)-Encoded RNA 2 (EBER2) but Not EBER1 Plays a Critical Role in EBV-Induced B-Cell Growth Transformation. J. Virol. 81: 11236-11245 [Abstract] [Full Text]
Hong, G. K., Gulley, M. L., Feng, W.-H., Delecluse, H.-J., Holley-Guthrie, E., Kenney, S. C. (2005). Epstein-Barr Virus Lytic Infection Contributes to Lymphoproliferative Disease in a SCID Mouse Model. J. Virol. 79: 13993-14003 [Abstract] [Full Text]
Ambrosino, C., Palmieri, C., Puca, A., Trimboli, F., Schiavone, M., Olimpico, F., Ruocco, M. R., di Leva, F., Toriello, M., Quinto, I., Venuta, S., Scala, G. (2002). Physical and Functional Interaction of HIV-1 Tat with E2F-4, a Transcriptional Regulator of Mammalian Cell Cycle. J. Biol. Chem. 277: 31448-31458 [Abstract] [Full Text]
van Esser, J. W. J., van der Holt, B., Meijer, E., Niesters, H. G. M., Trenschel, R., Thijsen, S. F. T., van Loon, A. M., Frassoni, F., Bacigalupo, A., Schaefer, U. W., Osterhaus, A. D. M. E., Gratama, J. W., Lowenberg, B., Verdonck, L. F., Cornelissen, J. J. (2001). Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 98: 972-978 [Abstract] [Full Text]
Haddad, E., Paczesny, S., Leblond, V., Seigneurin, J.-M., Stern, M., Achkar, A., Bauwens, M., Delwail, V., Debray, D., Duvoux, C., Hubert, P., de Ligny, B. H., Wijdenes, J., Durandy, A., Fischer, A. (2001). Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial. Blood 97: 1590-1597 [Abstract] [Full Text]
Fayad, L., Keating, M. J., Reuben, J. M., O'Brien, S., Lee, B.-N., Lerner, S., Kurzrock, R. (2001). Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood 97: 256-263 [Abstract] [Full Text]
Tartour, E., Fossiez, F., Joyeux, I., Galinha, A., Gey, A., Claret, E., Sastre-Garau, X., Couturier, J., Mosseri, V., Vives, V., Banchereau, J., Fridman, W. H., Wijdenes, J., Lebecque, S., Sautees-Fridman, C. (1999). Interleukin 17, a T-cell-derived Cytokine, Promotes Tumorigenicity of Human Cervical Tumors in Nude Mice. Cancer Res. 59: 3698-3704 [Abstract] [Full Text]
Groux, H., Cottrez, F., Montpellier, C., Quatannens, B., Coll, J., Stehelin, D., Auriault, C. (1997). Isolation and Characterization of Transformed Human T-Cell Lines Infected by Epstein-Barr Virus. Blood 89: 4521-4530 [Abstract] [Full Text]
Ambrosino, C., Ruocco, M. R., Chen, X., Mallardo, M., Baudi, F., Trematerra, S., Quinto, I., Venuta, S., Scala, G. (1997). HIV-1 Tat Induces the Expression of the Interleukin-6 (IL6) Gene by Binding to the IL6 Leader RNA and by Interacting with CAAT Enhancer-binding Protein beta �(NF-IL6) Transcription Factors. J. Biol. Chem. 272: 14883-14892 [Abstract] [Full Text]
Moore, P. S., Boshoff, C., Weiss, R. A., Chang, Y. (1996). Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV. Science 274: 1739-1744 [Abstract] [Full Text]
Ruocco, M. R., Chen, X., Ambrosino, C., Dragonetti, E., Liu, W., Mallardo, M., De Falco, G., Palmieri, C., Franzoso, G., Quinto, I., Venuta, S., Scala, G. (1996). Regulation of HIV-1 Long Terminal Repeats by Interaction of C/EBP(NF-IL6) and NF-kappa B/Rel Transcription Factors. J. Biol. Chem. 271: 22479-22486 [Abstract] [Full Text]